SAN DIEGO, Dec. 12, 2022 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the chief in spine expertise innovation, centered on reworking spine surgical procedure with minimally disruptive, procedurally built-in options, introduced immediately that Chief Govt Officer Chris Barry will take part within the 41st Annual J.P. Morgan Healthcare Convention in San Francisco on Thursday, January 12, 2023 at 7:30 a.m. PT.
A stay webcast of the presentation can be obtainable on-line from the Investor Relations web page of the Firm’s web site at www.nuvasive.com. After the stay webcast, a replay of the presentation will stay obtainable on the web site for 30 days.
NuVasive, Inc. (NASDAQ: NUVA) is the chief in spine expertise innovation, with a mission to rework surgical procedure, advance care, and alter lives. The Firm’s less-invasive, procedurally built-in surgical options are designed to ship reproducible and clinically confirmed outcomes. The Firm’s complete procedural portfolio contains surgical entry devices, spinal implants, fixation techniques, biologics, software program for surgical planning, navigation and imaging options, magnetically adjustable implant techniques for spine and orthopedics, and intraoperative neuromonitoring expertise and repair choices. With greater than $1 billion in internet gross sales, NuVasive operates in additional than 50 nations serving surgeons, hospitals, and sufferers. For extra info, please go to www.nuvasive.com.
NuVasive cautions you that statements included on this information launch that aren’t an outline of historic info are forward-looking statements that contain dangers, uncertainties, assumptions and different components which, if they don’t materialize or show appropriate, might trigger NuVasive’s outcomes to vary materially from historic outcomes or these expressed or implied by such forward-looking statements. The potential dangers and uncertainties which contribute to the unsure nature of those statements embrace, amongst others, dangers related to acceptance of the Firm’s surgical merchandise and procedures by spine surgeons and hospitals, improvement and acceptance of latest merchandise or product enhancements, scientific and statistical verification of the advantages achieved by way of the usage of NuVasive’s merchandise, the Firm’s potential to adequately handle stock because it continues to launch new merchandise, its potential to recruit and retain administration and key personnel, and the opposite dangers and uncertainties described in NuVasive’s information releases and periodic filings with the Securities and Trade Fee. NuVasive’s public filings with the Securities and Trade Fee can be found at www.sec.gov. NuVasive assumes no obligation to replace any forward-looking assertion to replicate occasions or circumstances arising after the date on which it was made.
SOURCE NuVasive, Inc.